Determinants affecting quality of life: Implications for pharmacist counseling for patients with breast cancer in Japan

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 1, 2012, Pages 59-64

  Kawaguchi, Takashi ^a   Iwase, Satoru ^b   Koinuma, Masayoshi ^c   Onodera, Yuki ^a   Takeuchi, Hironori ^a   Umeda, Megumi ^d   Matsunaga, Tadaharu ^d   Unezaki, Sakae ^a   Nagumod, Yoshinori ^d  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d Nagumo Clinic   (Japan)

Author keywords

Adjuvant therapy; Breast cancer; Patient centered; Pharmacist counseling; Quality of life

Indexed keywords

ADULT; ANOREXIA; ARTICLE; BREAST CARCINOMA; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER SURGERY; EMOTION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MULTIPLE LINEAR REGRESSION ANALYSIS; PATH ANALYSIS; PATIENT COUNSELING; PHARMACIST ATTITUDE; QUALITY OF LIFE; QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ADULT; APPETITE; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COUNSELING; EMOTIONS; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; JAPAN; LINEAR MODELS; MIDDLE AGED; PHARMACISTS; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84855675690     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.59     Document Type: Article

References (50)

1. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn. J. Clin. Oncol., 41, 139-147 (2011).
2. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1995: estimates based on data from nine population-based cancer registries. Jpn. J. Clin. Oncol., 30, 318-321 (2000).
3. Fallowfield L. Quality of life: a new perspective for cancer patients. Nat. Rev. Cancer, 2, 873-879 (2002).
4. Iwamitsu Y, Shimoda K, Abe H, Tani T, Okawa M, Buck R. Anxiety, emotional suppression, and psychological distress before and after breast cancer diagnosis. Psychosomatics, 46, 19-24 (2005).
5. Arndt V, Stegmaier C, Ziegler H, Brenner H. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer, 107, 2496-2503 (2006).
6. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jørgensen T. Depression as a prognostic factor for breast cancer mortality. Psychosomatics, 44, 24-30 (2003).
7. Ayres A, Hoon PW, Franzoni JB, Matheny KB, Cotanch PH, Takayanagi S. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J. Psychosom. Res., 38, 393-402 (1994).
8. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ, 330, 702 (2005).
9. Golden-Kreutz DM, Andersen BL. Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psychooncology, 13, 211-220 (2004).
10. Ando N, Iwamitsu Y, Kuranami M, Okazaki S, Wada M, Yamamoto K, Todoroki K, Watanabe M, Miyaoka H. Psychological characteristics and subjective symptoms as determinants of psychological distress in patients prior to breast cancer diagnosis. Support. Care Cancer, 17, 1361-1370 (2009).
11. Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL, Clay KF, Ahles TA. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer, 107, 2924-2931 (2006).
12. Wong-Kim EC, Bloom JR. Depression experienced by young women newly diagnosed with breast cancer. Psychooncology, 14, 564-573 (2005).
13. Massie MJ. Prevalence of depression in patients with cancer. J. Natl. Cancer Inst. Monogr., 32, 57-71 (2004).
14. Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J. Clin. Oncol., 23, 8025-8032 (2005).
15. Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A. Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. J. Clin. Oncol., 22, 4261-4271 (2004).
16. Fallowfield LJ, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coombes RC, Hall E. Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J. Clin. Oncol., 24, 910-917 (2006).
17. Hack TF, Degner LF, Dyck DG. Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis. Soc. Sci. Med., 39, 279-289 (1994).
18. Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O'Neil J, Bilodeau B, Watson P, Mueller B. Information needs and decisional preferences in women with breast cancer. JAMA, 277, 1485-1492 (1997).
19. Jaehde U, Liekweg A, Simons S, Westfeld M. Minimising treatment- associated risks in systemic cancer therapy. Pharm. World Sci., 30, 161-168 (2008).
20. Liekweg A, Westfeld M, Jaehde U. From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support. Care Cancer, 12, 73-79 (2004).
21. Ikesue H, Oishi R. Oncology pharmacy specialists in oncology. Gan To Kagaku Ryoho, 35, 578-582 (2008).
22. Onda M, Sakurai H, Hayase Y, Sakamaki H, Arakawa Y, Yasukawa F. Effects of patient-pharmacist communication in the treatment of asthma. Yakugaku Zasshi, 129, 427-433 (2009).
23. Chewning B, Wiederholt JB. Concordance in cancer medication management. Patient Educ. Couns., 50, 75-78 (2003).
24. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch. Intern. Med., 166, 955-964 (2006).
25. Bruner DW. Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials? J. Clin. Oncol., 25, 5345-5347 (2007).
26. Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, Rothman M; PRO Harmonization Group. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health, 6, 522-531 (2003).
27. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient reported outcome measures in healthcare settings. BMJ, 340(jan18 1), c186 (2010).
28. Basch E, Jia X, Heller G, Barz A, Sit L, Fruscione M, Appawu M, Iasonos A, Atkinson T, Goldfarb S, Culkin A, Kris MG, Schrag D. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes. J. Natl. Cancer Inst., 101, 1624-1632 (2009).
29. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst., 85, 365-376 (1993).
30. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J. Clin. Oncol., 14, 2756-2768 (1996).
31. Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S, Noguchi Y, Ogasawara H, Yoshida K. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur. J. Cancer, 34, 810-815 (1998).
32. Okamoto T, Shimozuma K, Katsumata N, Koike M, Hisashige A, Tanaka K, Ohsumi S, Saito M, Shikama N, Mitsumori M, Yamauchi C, Watanabe T. Task Force of the Japanese Breast Cancer Society for 'The Development of Guidelines for Quality of Life Assessment Studies of Breast Cancer Patients.' Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in Japan. Breast Cancer, 10, 204-213 (2003).
33. Faul F, Erdfelder E, Lang AG, Buchner AG. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods, 39, 175-191 (2007).
34. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods, 41, 1149-1160 (2009).
35. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet, 362, 640-650 (2003).
36. Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T; ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet, 359, 2131-2139 (2002).
37. Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res. Treat., 38, 183-199 (1996).
38. Yuan Y, Hay JW, McCombs JS. Effects of ambulatory-care pharmacist consultation on mortality and hospitalization. Am. J. Manag. Care, 9, 45-56 (2003).
39. Stevens VJ, Shneidman RJ, Johnson RE, Boles M, Steele PE, Lee NL. Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention. West. J. Med., 176, 92-96 (2002).
40. Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J. Natl. Cancer Inst., 96, 376-387 (2004).
41. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J. Natl. Cancer Inst., 94, 39-49 (2002).
42. Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH. Predictors of sexual health in women after a breast cancer diagnosis. J. Clin. Oncol., 17, 2371-2380 (1999).
43. Takahashi M, Ohno S, Inoue H, Kataoka A, Yamaguchi H, Uchida Y, Oshima A, Abiru K, Ono K, Noguchi R, Kai I. Impact of breast cancer diagnosis and treatment on women's sexuality: a survey of Japanese patients. Psychooncology, 17, 901-907 (2008).
44. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T. GSSAB Investigators' Group. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int. J. Impot. Res., 17, 39-57 (2005).
45. Takahashi M, Kai I. Sexuality after breast cancer treatment: changes and coping strategies among Japanese survivors. Soc. Sci. Med., 61, 1278-1290 (2005).
46. Moreira ED Jr, Brock G, Glasser DB, Nicolosi A, Laumann EO, Paik A, Wang T, Gingell C. GSSAB Investigators' Group. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int. J. Clin. Pract., 59, 6-16 (2005).
47. Okamoto S. Transformations in doctor-patient communication in Japan: the role of cultural factors. Patient Educ. Couns., 65, 153-155 (2007).
48. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A. EORTC Clinical Groups. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol., 10, 865-871 (2009).
49. Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann. Oncol., 22, 761-772 (2011).
50. van der Meulen N, Jansen J, van Dulmen S, Bensing J, van Weert J. Interventions to improve recall of medical information in cancer patients: a systematic review of the literature. Psychooncology, 17, 857-868 (2008).